Description
The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to advance precision medicine in pregnant women, lactating women, and children. The research should focus on developing novel tools, models, and technologies that could have a direct clinical or health impact, enhancing the understanding of the underlying mechanisms of drug action, and discovering and developing novel therapeutics or enhancing the usage of existing drugs or drug repurposing for safer and more effective medications in pregnant and lactating women, neonates, and children. The overall goal is to improve safe and effective precision therapeutics for pregnant and lactating women, fetuses, neonates, and children, including those with disabilities.
• The opportunity is open to various types of applicants, including small businesses, special district governments, nonprofits, public and state-controlled institutions of higher education, and others.
• The funding instrument for this opportunity is a grant.
• The funding activity categories for this opportunity include education, health, and income security and social services.
• The opportunity has a closing date of May 7, 2026.
• The opportunity is expected to have around 100 applications, with an expected application size of 0.
• The opportunity is open to applicants from various sectors, including federal agencies, faith-based or community-based organizations, and regional organizations.